For many, Novavax is #1 – the one and only COVID vaccine they would consider. This enthusiasm for Novavax isn’t new. As far back as 2022, news reports described a kind of Novavax fan club – a term ...
Novavax, Inc. (NVAX) announced Friday that doses of the Novavax COVID-19 Vaccine, Adjuvanted (2024-2025 Formula) (NVX-CoV2705) to ...
The FDA has authorized Novavax's new formula, adding to a repertoire of revamped COVID vaccines. Here's what to know about cost and more. Jessica Rendall Wellness Reporter Jessica is a writer on ...
Here's what to know about the latest vaccines, who needs them and how they help prevent the more serious effects of COVID-19. The FDA granted emergency use authorization last week to an updated ...
Many healthy people have immunity from vaccines and previous infection. This is a KFF Health News story. The U.S. Food and Drug Administration has approved an updated COVID-19 shot for everyone 6 ...
Kaiser Permanente expects to begin making vaccines available by mid-September and possibly earlier in some locations. Sutter Health is also aiming for a mid-September rollout. The CDC recommends ...
In early 2022, I cared for one of the first patients with mpox in Massachusetts. As an infectious diseases physician, I remember the deep uncertainty I felt, and the fear in my patient’s eyes as ...
CORRECTION: An earlier version of this story misstated the number of RSV vaccines approved for older adults. There are three vaccines. The pools are closing, the kids are back in school and ...
Drugmakers have supplies ready to ship that are necessary to stop a potential pandemic. But W.H.O. regulations have slowed access. By Stephanie Nolen Stephanie Nolen covered the 2022 mpox outbreak ...
Millions of updated COVID-19 vaccines will soon be available ahead of the flu and fall-winter season. On Thursday, Aug. 22, the U.S. Food and Drug Administration approved and granted emergency use ...
Last year was the first year that the US had vaccines available to protect against all three major respiratory viruses — Covid-19, flu and RSV — but vaccine uptake was low for the season.